Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin versus lidocaine for blunting hemodynamic response to intubation
IRCT20250608066112N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, double-blind trial of lidocaine and oxytocin in None (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Change in systolic blood pressure after intubation, Change in diastolic blood pressure after intubation and 3 more. Started Jul 2025; status: completed.
02
Drugs
lidocaineoxytocin
Beyond the preview
Go deeper on IRCT20250608066112N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250608066112N1.